Conventional medical management of inflammatory bowel disease.
about
Low dose naltrexone for induction of remission in Crohn's diseaseLow dose naltrexone for induction of remission in Crohn's diseaseImmunomodulatory functions of type I interferonsAssessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative dataMesalamine in the treatment and maintenance of remission of ulcerative colitisGastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale SurveyMultiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in miceImpact of medical therapy on patients with Crohn's disease requiring surgical resection.Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.Inflammatory bowel disease: clinical aspects and treatments.Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.Five-aminosalicylic Acid: an update for the reappraisal of an old drugEffectiveness and risk associated with infliximab alone and in combination with immunosuppressors for Crohn's disease: a systematic review and meta-analysisSelect a suitable treatment strategy for Crohn's disease: step-up or top-down.Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease.The effect of calendula officinalis in therapy of acetic Acid induced ulcerative colitis in dog as an animal modelUpdate on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009.Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National SurveyInfliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trialSerious Non-AIDS events: Immunopathogenesis and interventional strategies.Second Korean guidelines for the management of ulcerative colitis.Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.Update on chronic diarrhea: a run-through for the clinician.Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.Immunosuppressive and biologic therapy for ulcerative colitis.Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis.Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure.Medical management of ulcerative colitis with a specific focus on 5-aminosalicylates.Conventional drug therapy for inflammatory bowel disease.The application of RNAi-based treatments for inflammatory bowel disease.Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitisUse of Immunomodulators and Biologics Before, During, and After Pregnancy.Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models.More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
P2860
Q24200319-504BDB53-11B4-4CC7-8A0A-48198321394AQ24201218-54EC6764-4FAE-41D9-B809-42882F469406Q26823904-8DE91B50-FEF8-4ED7-AD0F-C22C78358686Q26864906-B150A40F-9322-4BC3-9106-022A89E8A211Q26865546-B79F3427-58B4-4768-8CC4-59EA55A3E0C4Q30489693-631B0FDB-AF75-4444-9ACA-77FE0FD3EEC6Q30571620-39833F86-98A2-4B22-9679-AE2E92E6FA3AQ30902172-968617E0-B14C-4CA0-B418-EB3BBD83B2BAQ33564081-8C35961C-C01B-4297-9F08-DAE4C6AD21B1Q33608698-B845DD73-579C-4A56-B677-516D2F6C286EQ34137388-7E791D1D-2170-4EA0-9424-3525A01CF5A6Q34275637-B5DC6201-4484-4C23-A20F-8858FEEBAE59Q34431476-C794B940-650B-4677-B26E-47E40B6D10DCQ34795735-E428839F-5C0B-4703-A31B-B4B896ACAA24Q35061210-9E84DD02-7A32-4505-8642-53B7CE28EEFDQ35679414-B95064E3-01AA-4F59-A504-194E8E66F86BQ35721537-D376D1DA-3626-49BB-9694-E04DD4F001CEQ35876184-4E9105C8-5022-41B0-95CB-88D56B5D89B4Q36022249-77E396EF-B601-41E9-B985-4AD76C328EF2Q36144377-8F5CDE49-5D80-4889-8046-70EBC1035449Q36200041-429F4A1F-051D-40BD-9ED8-8DD53878A88BQ36265369-3D3936AE-DEB0-406F-9952-C51D8E76F5ECQ36599575-56DE2224-895E-4A73-BA29-7BDE961E61B2Q37015505-E3FECD5C-ADBD-40CD-B0FF-CF7D0A81923FQ37196938-5C89F35F-F4EE-4097-8CF6-73B3996E69F7Q37418140-5DD915BA-D858-422C-9FA2-B61679638122Q37662503-B607171E-4CFE-4336-AD8A-1901DCD86FDBQ37947158-C3041C8F-155B-43DE-B5E2-DF2FB6752463Q38035797-F69C00FE-FD7C-4543-9D88-0D8645D5C343Q38056526-00577F0E-809D-4C8E-8506-280A0DC1166AQ38060831-E1FA7505-3FF6-448C-B70F-F7703ABDA4EEQ38117907-0AEEDC3B-3EED-47BE-A3A5-1BA448575FA7Q38160896-5A70E74D-2C75-40BB-9C01-7A51BA5D42E3Q38212225-24F2C4A3-769B-4683-A6D7-B01AD182CE17Q38293796-5185EA1A-4F14-4229-B3D7-4F64018BDABFQ38382964-E150A951-EF45-45BC-8153-1453521E2464Q38399146-96B939F2-F6B5-48DC-9D08-FB05FB33A83EQ38601306-D4BEA6DA-AD48-41A2-BE2D-1B666E0EAD47Q38694522-E2D1BEF9-F90D-4A09-B70D-23C5B1F0DC4AQ38712266-479315F1-0749-4254-B7B9-214F7C3F0517
P2860
Conventional medical management of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Conventional medical management of inflammatory bowel disease.
@en
Conventional medical management of inflammatory bowel disease.
@nl
type
label
Conventional medical management of inflammatory bowel disease.
@en
Conventional medical management of inflammatory bowel disease.
@nl
prefLabel
Conventional medical management of inflammatory bowel disease.
@en
Conventional medical management of inflammatory bowel disease.
@nl
P1433
P1476
Conventional medical management of inflammatory bowel disease.
@en
P2093
Daniel Burger
Simon Travis
P304
1827-1837.e2
P356
10.1053/J.GASTRO.2011.02.045
P407
P577
2011-05-01T00:00:00Z